President John Dramani Mahama has urged Indian companies to invest in Ghana’s pharmaceutical and vaccine manufacturing sectors, saying improved economic conditions and the government’s drive towards health sovereignty have created fresh opportunities.
Speaking at a meeting with India’s External Affairs Minister, Dr Subrahmanyam Jaishankar, Mr Mahama said Ghana’s economy was stable, inflation was falling and the cedi was holding its own.
He said those conditions made Ghana an attractive destination for investment, particularly in industries that could strengthen the country’s ability to produce essential medicines and vaccines domestically.
The president pointed to the partnership between Indian-linked Atlantic Life Sciences and Ghanaian company KinaPharma as an example of how local and international cooperation could support the expansion of vaccine manufacturing in Ghana.
He also referred to the expanding trade relationship between Ghana and India. Ghanaian exports to India have increased from about US$3 billion to nearly US$7 billion, while Ghana continues to benefit from Indian agricultural machinery, automobiles and buses.
Dr Jaishankar delivered warm greetings from Indian Prime Minister Narendra Modi and President Droupadi Murmu during the meeting.
He said both leaders wanted the comprehensive partnership between Ghana and India to be developed further through new areas of practical cooperation.
The talks are part of wider efforts to strengthen the longstanding relationship between the two countries, with infrastructure, ICT, health, trade and investment among the areas of cooperation.
